DOCSLIB.ORG

Expression of Kallikrein-Related Peptidase 7 Predicts Poor Prognosis in Patients with Unresectable Pancreatic Ductal Adenocarcinoma

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Expression of Kallikrein-Related Peptidase 7 Predicts Poor Prognosis in Patients with Unresectable Pancreatic Ductal Adenocarcinoma Published OnlineFirst May 9, 2012; DOI: 10.1158/1055-9965.EPI-11-1079 Cancer Epidemiology, Research Article Biomarkers & Prevention Expression of Kallikrein-Related Peptidase 7 Predicts Poor Prognosis in Patients with Unresectable Pancreatic Ductal Adenocarcinoma Vladimir Iakovlev1, Eric R. Siegel3, Ming-Sound Tsao2, and Randy S. Haun4 Abstract Background: Kallikrein-related peptidase 7 (KLK7) is overexpressed in pancreatic ductal adenocarcinomas (PDAC). The aims of this study were to examine the expression of KLK7 during progression of pancreatic intraepithelial neoplasia (PanIN) to invasive PDAC and to assess its prognostic significance for PDAC. Methods: Immunohistochemistry was used to assess KLK7 expression using a tissue microarray (TMA) and full sections of pancreatic tissue containing normal tissue, PanIN, and invasive adenocarcinoma, and the association between KLK7 expression and prognosis was examined by a population-based pancreatic cancer TMA. Results: Normal pancreatic epithelium was negative for KLK7 in either TMAs or full sections. Analysis by TMAs showed that 91% of cases showed KLK7 positivity in the adenocarcinoma component, which was significantly higher than PanIN 2/3. In full tissue sections of PDAC, KLK7 expression was detected in less than 1% of cells among PanIN 1A lesions, and increased with grade among PanIN 1B and PanIN2/3 lesions before reaching 69% in the invasive PDAC. In patients with unresected PDAC, KLK7 positivity was significantly associated with shorter overall survival. Conclusions: Aberrant KLK7 expression starts in intermediate-to-late stages of PanIN progression, and KLK7-positive staining is associated with almost a three-fold increase in mortality rate of patients with unresected PDAC. Impact: The association of KLK7 expression and poor outcome of patients with unresectable PDAC suggests that inhibiting either KLK7 expression and/or activity could be a therapeutic strategy. Because the vast majority of patients present with unresectable disease, such an intervention could have a significant impact upon the overall survival of this patient population. Cancer Epidemiol Biomarkers Prev; 21(7); 1135–42. Ó2012 AACR. Introduction during progression of low-grade pancreatic intraepithe- Pancreatic cancer is the fourth most common cause of lial neoplasms (PanIN) to infiltrating adenocarcinomas cancer-related deaths in men and women in the United has increased substantially in the past decade, prognosis States (1). Similar to other epithelial cancers, the devel- of patients upon diagnosis remains extremely poor. Most opment of pancreatic ductal adenocarcinomas (PDAC) is patients present with inoperable, locally advanced or multistep, with intermediate steps being defined by a metastatic disease; thus, median survival times for series of morphologic changes and molecular alterations patients diagnosed with locally advanced disease ranges during progression from intraepithelial lesions to inva- between 6 and 10 months, compared with only 3 to 6 sive carcinoma (reviewed in refs. 2, 3). Although our months for patients with metastatic disease (4). Even understanding of the genetic changes that accumulate patients who undergo resection of localized adenocarci- noma of the head of pancreas without metastatic spread Authors' Affiliations: 1Keenan Research Centre of the Li Ka Shing Knowl- have a median survival of only 13 to 15 months and a 15% edge Institute of St. Michael's Hospital, 2University Health Network, to 20% rate of long-term survival (5). Thus, numerous Princess Margaret Hospital/Ontario Cancer Centre and Department of prognostic factors have been assessed for their impact on Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; and Departments of 3Biostatistics and 4Pharmaceutical survival following surgical resection of pancreatic ade- Sciences, Colleges of 3Medicine and 4Pharmacy, Winthrop P. Rockefeller nocarcinoma, and several have been shown to correlate Cancer Institute, University of Arkansas for Medical Sciences, and 4Central Arkansas Veterans Healthcare System, Little Rock, Arkansas with patient outcome, including clinicopathologic staging (e.g., tumor size, lymph node status), tumor biology, Corresponding Author: Randy S. Haun, Department of Pharmaceutical Sciences, University of Arkansas for Medical Sciences, 4301 W. Markham intraoperative factors, adjuvant chemoradiation therapy, St., #753, Little Rock, AR 72205. Phone: 501-686-8594; Fax: 501-686- and immunohistochemical markers such as VEGF, Bcl-2, 6517; E-mail: [email protected] p16, and p53 (6–9). doi: 10.1158/1055-9965.EPI-11-1079 We previously generated an expression profile of Ó2012 American Association for Cancer Research. serine proteases expressed in both normal and www.aacrjournals.org 1135 Downloaded from cebp.aacrjournals.org on September 28, 2021. © 2012 American Association for Cancer Research. Published OnlineFirst May 9, 2012; DOI: 10.1158/1055-9965.EPI-11-1079 Iakovlev et al. adenocarcinoma pancreatic tissues and found that Immunohistochemical staining kallikrein-related peptidase 7 (KLK7) is overexpressed Immunohistochemical staining was carried out as pre- in PDACs (10). KLK7, a chymotryptic-like serine pro- viously described (10). Briefly, formalin-fixed, paraffin- tease, was initially purified and characterized from embedded sections were deparaffinized and rehydrated human skin extracts and is thought to play a role in in xylene followed by graded ethanol. Following antigen desquamation of human skin (11, 12). Increasingly, retrieval, endogenous peroxidase activity was quenched however, the KLK7 transcript and/or KLK7 protein by hydrogen peroxide treatment followed by a protein have been found to be overexpressed in human cancers. block (Dako serum-free protein block). Sections were Other laboratories have showed that it is overexpressed incubated with a goat anti-hKLK7 antibody (R&D Sys- in ovarian (13, 14), squamous cervical (15), and breast tems, diluted 1:800) overnight in a humidified chamber at cancers (16). In the current study, we used immunohis- 4C. Immunoreactive staining was detected using a þ tochemistry to examine the expression of KLK7 in DAKO LSAB peroxidase system followed by hematox- lesions representing stages of PDAC development and ylin counterstain. to determine whether there is a correlation between KLK7 expression and overall survival (OS) in patients Evaluation of immunohistochemical analysis with pancreatic adenocarcinoma. In the initial analysis of the TMAs, each spot was assessed for the presence of the following components: normal pancreatic ducts, 3 grades of PanIN, or invasive Materials and Methods adenocarcinoma. KLK7 staining was recorded as positive Tissue samples in each component when there was unequivocal staining The study was approved by the Research Ethics Board in any number of cells. The number and percentage of at the University Health Network and Institutional spots with positivity in each component was calculated. Review Board at the University of Arkansas for Medical This TMA analysis showed higher frequency of KLK7 Sciences. For the initial analysis of KLK7 expression dur- positivity in more advanced lesions, so our next step was ing pancreatic adenocarcinoma tumorigenesis, tissue to quantify KLK7 expression using larger samples. Full microarrays (TMA) assembled by sampling of paraffin tissue sections of the blocks used for the TMA sampling blocks of 36 cases of resected PDACs were used (17). were visually assessed for the percentage of KLK7-posi- Normal, PanIN, and adenocarcinoma components were tive cells in each component. Then, after confirming that identified in TMA spots and assessed for KLK7 staining. KLK7 expression correlates with morphologic steps of Because of the nature of TMAs, individual spots contained disease progression, population-based TMAs were ana- one, several, or no targeted components (normal, PanIN, lyzed for associations between KLK7 positivity and clin- or adenocarcinoma); thus, 49 spots from 22 cases con- ical outcome. These TMAs were analyzed digitally using tained adenocarcinoma component, 17 spots from 17 previously described techniques (19, 20). Briefly, the cases contained PanIN 1 lesions, 46 spots from 35 cases KLK7-stained slide was scanned using an Aperio Scan- contained PanIN 2/3 lesions, and 32 spots contained Scope scanning system (Aperio Technologies). Each TMA normal ducts from 21 cases. After the initial analysis of spot was saved as a separate file, then all parts of the tissue the TMAs, full sections were prepared from PDAC tumor except for the component of interest were erased using blocks obtained following surgical resection and 22 cases "Photoshop CS3" (Adobe Systems). Then, the images were were found to contain the targeted components: normal processed to generate 2 sets of files: tissue masks to limit pancreatic ducts, invasive cancer, and at least one grade of analysis within the selected areas and signal images to PanIN in the same section. These full sections of 22 cases assess KLK7 staining intensity. The tissue masks were were evaluated for KLK7 immunoreactivity quantitative- obtained by thresholding through a value separating the ly. The full sections were chosen to reduce the biases of the clear background of histologic slides from the tissue. The TMA, such as small areas subject to heterogeneity effects signal images were generated by collecting the range of and unbalanced representation of cases by a different KLK7 brown color, erasing nonbrown pixels, and con- number of cores
Load more

Recommended publications
  • Ablation of Kallikrein 7 (KLK7) in Adipose Tissue Ameliorates
    Cell. Mol. Life Sci. DOI 10.1007/s00018-017-2658-y Cellular and Molecular LifeSciences ORIGINAL ARTICLE Ablation of kallikrein 7 (KLK7) in adipose tissue ameliorates metabolic consequences of high fat diet‑induced obesity by counteracting adipose tissue infammation in vivo Konstanze Zieger1 · Juliane Weiner1,2 · Anne Kunath2,3 · Martin Gericke4 · Kerstin Krause2 · Matthias Kern3 · Michael Stumvoll2 · Nora Klöting3,5 · Matthias Blüher2,5 · John T. Heiker1,2,5 Received: 21 April 2017 / Revised: 4 September 2017 / Accepted: 13 September 2017 © The Author(s) 2017. This article is an open access publication Abstract Vaspin is an adipokine which improves glu- cytokine expression was signifcantly reduced in combina- cose metabolism and insulin sensitivity in obesity. Kal- tion with an increased percentage of alternatively activated likrein 7 (KLK7) is the frst known protease target inhib- (anti-infammatory) M2 macrophages in epigonadal adipose / ited by vaspin and a potential target for the treatment of tissue of ATKlk7− −. Taken together, by attenuating adipose metabolic disorders. Here, we tested the hypothesis that tissue infammation, altering adipokine secretion and epigo- inhibition of KLK7 in adipose tissue may benefcially afect nadal adipose tissue expansion, Klk7 defciency in adipose glucose metabolism and adipose tissue function. Therefore, tissue partially ameliorates the adverse efects of HFD- we have inactivated the Klk7 gene in adipose tissue using induced obesity. In summary, we provide frst evidence for conditional gene-targeting strategies in mice. Klk7-defcient a previously unrecognized role of KLK7 in adipose tissue / mice (ATKlk7− −) exhibited less weight gain, predominant with efects on whole body energy expenditure and insulin expansion of subcutaneous adipose tissue and improved sensitivity.
    [Show full text]
  • Analysis of the Indacaterol-Regulated Transcriptome in Human Airway
    Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2018/04/13/jpet.118.249292.DC1 1521-0103/366/1/220–236$35.00 https://doi.org/10.1124/jpet.118.249292 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 366:220–236, July 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the s Adverse and Therapeutic Effects of b2-Adrenoceptor Agonists Dong Yan, Omar Hamed, Taruna Joshi,1 Mahmoud M. Mostafa, Kyla C. Jamieson, Radhika Joshi, Robert Newton, and Mark A. Giembycz Departments of Physiology and Pharmacology (D.Y., O.H., T.J., K.C.J., R.J., M.A.G.) and Cell Biology and Anatomy (M.M.M., R.N.), Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Received March 22, 2018; accepted April 11, 2018 Downloaded from ABSTRACT The contribution of gene expression changes to the adverse and activity, and positive regulation of neutrophil chemotaxis. The therapeutic effects of b2-adrenoceptor agonists in asthma was general enriched GO term extracellular space was also associ- investigated using human airway epithelial cells as a therapeu- ated with indacaterol-induced genes, and many of those, in- tically relevant target. Operational model-fitting established that cluding CRISPLD2, DMBT1, GAS1, and SOCS3, have putative jpet.aspetjournals.org the long-acting b2-adrenoceptor agonists (LABA) indacaterol, anti-inflammatory, antibacterial, and/or antiviral activity. Numer- salmeterol, formoterol, and picumeterol were full agonists on ous indacaterol-regulated genes were also induced or repressed BEAS-2B cells transfected with a cAMP-response element in BEAS-2B cells and human primary bronchial epithelial cells by reporter but differed in efficacy (indacaterol $ formoterol .
    [Show full text]
  • Aberrant Human Tissue Kallikrein Levels in the Stratum Corneum and Serum of Patients with Psoriasis: Dependence on Phenotype, Severity and Therapy N
    CLINICAL AND LABORATORY INVESTIGATIONS DOI 10.1111/j.1365-2133.2006.07743.x Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy N. Komatsu,* à K. Saijoh,§ C. Kuk,* F. Shirasaki,à K. Takeharaà and E.P. Diamandis* *Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 1L5, Canada àDepartment of Dermatology and §Department of Hygiene, Graduate School of Medical Science, School of Medicine, Kanazawa University, Kanazawa, Japan Summary Correspondence Background Human tissue kallikreins (KLKs) are a family of 15 trypsin-like or Eleftherios P. Diamandis. chymotrypsin-like secreted serine proteases (KLK1–KLK15). Multiple KLKs have E-mail: [email protected] been quantitatively identified in normal stratum corneum (SC) and sweat as can- didate desquamation-related proteases. Accepted for publication 7 November 2006 Objectives To quantify KLK5, KLK6, KLK7, KLK8, KLK10, KLK11, KLK13 and KLK14 in the SC and serum of patients with psoriasis, and their variation Key words between lesional and nonlesional areas and with phenotype, therapy and severity. diagnostic marker, human kallikreins, psoriasis, The overall SC serine protease activities were also measured. serine proteases, stratum corneum, therapy Methods Enzyme-linked immunosorbent assays and enzymatic assays were used. Conflicts of interest Results The lesional SC of psoriasis generally contained significantly higher levels None declared. of all KLKs. KLK6, KLK10 and KLK13 levels were significantly elevated even in the nonlesional SC. The overall trypsin-like, plasmin-like and furin-like activities were significantly elevated in the lesional SC.
    [Show full text]
  • Human Tissue Kallikrein Expression in the Stratum Corneum and Serum of Atopic Dermatitis Patients
    DOI:10.1111/j.1600-0625.2007.00562.x www.blackwellpublishing.com/EXD Original Article Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients Nahoko Komatsu1,2,3,4, Kiyofumi Saijoh4, Cynthia Kuk1, Amber C. Liu1, Saba Khan1, Fumiaki Shirasaki3, Kazuhiko Takehara3 and Eleftherios P. Diamandis1,2 1Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada; 2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; 3Department of Dermatology, Graduate School of Medical Science, School of Medicine, Kanazawa University, Kanazawa, Japan; 4Department of Hygiene, Graduate School of Medical Science, School of Medicine, Kanazawa University, Kanazawa, Japan Correspondence: Eleftherios P. Diamandis, MD, PhD, FRCPC, Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, ON M5G 1X5, Canada, Tel.: +1 416 586 8443, Fax: +1 416 586 8628, e-mail: [email protected] Accepted for publication 9 March 2007 Abstract: Human tissue kallikreins are a family of 15 trypsin- or differ significantly. In the serum of AD patients, KLK8 was chymotrypsin-like secreted serine proteases (KLK1–KLK15). Many significantly elevated and KLK5 and KLK11 were significantly KLKs have been identified in normal stratum corneum (SC) and decreased. However, their serum levels were not modified by sweat, and are candidate desquamation-related proteases. We corticosteroid topical agents. The alterations of KLK levels in the report quantification by enzyme-linked immunosorbent assay SC of AD were more pronounced than those in the serum. KLK7 (ELISA) of KLK5, KLK6, KLK7, KLK8, KLK10, KLK11, KLK13 and in the serum was significantly correlated with eosinophil counts in KLK14 in the SC and serum of atopic dermatitis (AD) patients by the blood of AD patients, while KLK5, KLK8 and KLK11 were ELISA, and examine their variation with clinical phenotype, significantly correlated with LDH in the serum.
    [Show full text]
  • 1 No. Affymetrix ID Gene Symbol Genedescription Gotermsbp Q Value 1. 209351 at KRT14 Keratin 14 Structural Constituent of Cyto
    1 Affymetrix Gene Q No. GeneDescription GOTermsBP ID Symbol value structural constituent of cytoskeleton, intermediate 1. 209351_at KRT14 keratin 14 filament, epidermis development <0.01 biological process unknown, S100 calcium binding calcium ion binding, cellular 2. 204268_at S100A2 protein A2 component unknown <0.01 regulation of progression through cell cycle, extracellular space, cytoplasm, cell proliferation, protein kinase C inhibitor activity, protein domain specific 3. 33323_r_at SFN stratifin/14-3-3σ binding <0.01 regulation of progression through cell cycle, extracellular space, cytoplasm, cell proliferation, protein kinase C inhibitor activity, protein domain specific 4. 33322_i_at SFN stratifin/14-3-3σ binding <0.01 structural constituent of cytoskeleton, intermediate 5. 201820_at KRT5 keratin 5 filament, epidermis development <0.01 structural constituent of cytoskeleton, intermediate 6. 209125_at KRT6A keratin 6A filament, ectoderm development <0.01 regulation of progression through cell cycle, extracellular space, cytoplasm, cell proliferation, protein kinase C inhibitor activity, protein domain specific 7. 209260_at SFN stratifin/14-3-3σ binding <0.01 structural constituent of cytoskeleton, intermediate 8. 213680_at KRT6B keratin 6B filament, ectoderm development <0.01 receptor activity, cytosol, integral to plasma membrane, cell surface receptor linked signal transduction, sensory perception, tumor-associated calcium visual perception, cell 9. 202286_s_at TACSTD2 signal transducer 2 proliferation, membrane <0.01 structural constituent of cytoskeleton, cytoskeleton, intermediate filament, cell-cell adherens junction, epidermis 10. 200606_at DSP desmoplakin development <0.01 lectin, galactoside- sugar binding, extracellular binding, soluble, 7 space, nucleus, apoptosis, 11. 206400_at LGALS7 (galectin 7) heterophilic cell adhesion <0.01 2 S100 calcium binding calcium ion binding, epidermis 12. 205916_at S100A7 protein A7 (psoriasin 1) development <0.01 S100 calcium binding protein A8 (calgranulin calcium ion binding, extracellular 13.
    [Show full text]
  • Page 1 of 76 Diabetes Diabetes Publish Ahead of Print, Published Online September 14, 2020
    Page 1 of 76 Diabetes Peters, Annette; Helmholtz Center Munich German Research Center for Environmental Health, Epidemiology Institute Waldenberger, Melanie; Helmholtz Center Munich German Research Center for Environmental Health, Molecular Epidemiology Diabetes Publish Ahead of Print, published online September 14, 2020 Diabetes Page 2 of 76 Deciphering the Plasma Proteome of Type 2 Diabetes Mohamed A. Elhadad1,2,3 MSc., Christian Jonasson4,5 PhD, Cornelia Huth2,6 PhD, Rory Wilson1,2 MSc, Christian Gieger1,2,6 PhD, Pamela Matias1,2,3 MSc, Harald Grallert1,2,6 PhD, Johannes Graumann7,8 PhD, Valerie Gailus-Durner9 PhD, Wolfgang Rathmann6,10 MD, Christine von Toerne11 PhD, Stefanie M. Hauck11 PhD, Wolfgang Koenig3,12,13 MD, FRCP, FESC, FACC, FAHA, Moritz F. Sinner3,14 MD, MPH, Tudor I Oprea15,16,17 MD, PhD, Karsten Suhre18 PhD, Barbara Thorand2,6 PhD, Kristian Hveem4,5 PhD, Annette Peters2,3,6,19 PhD, Melanie Waldenberger1,2,3 PhD 1. Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. 2. Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany 3. German Research Center for Cardiovascular Disease (DZHK), Partner site Munich Heart Alliance, Germany 4. K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health, NTNU - Norwegian University of Science and Technology, Trondheim, Norway 5. HUNT Research Center, Department of Public Health, NTNU - Norwegian University of Science and Technology, Levanger, Norway 6. German Center for Diabetes Research (DZD), München-Neuherberg, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany 7. Biomolecular Mass Spectrometry, Max Planck Institute for Heart and Lung Research, Ludwigstrasse 43, Bad Nauheim 61231, Germany 8.
    [Show full text]
  • Download, Or Email Articles for Individual Use
    Florida State University Libraries Faculty Publications The Department of Biomedical Sciences 2010 Functional Intersection of the Kallikrein- Related Peptidases (KLKs) and Thrombostasis Axis Michael Blaber, Hyesook Yoon, Maria Juliano, Isobel Scarisbrick, and Sachiko Blaber Follow this and additional works at the FSU Digital Library. For more information, please contact [email protected] Article in press - uncorrected proof Biol. Chem., Vol. 391, pp. 311–320, April 2010 • Copyright ᮊ by Walter de Gruyter • Berlin • New York. DOI 10.1515/BC.2010.024 Review Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis Michael Blaber1,*, Hyesook Yoon1, Maria A. locus (Gan et al., 2000; Harvey et al., 2000; Yousef et al., Juliano2, Isobel A. Scarisbrick3 and Sachiko I. 2000), as well as the adoption of a commonly accepted Blaber1 nomenclature (Lundwall et al., 2006), resolved these two fundamental issues. The vast body of work has associated 1 Department of Biomedical Sciences, Florida State several cancer pathologies with differential regulation or University, Tallahassee, FL 32306-4300, USA expression of individual members of the KLK family, and 2 Department of Biophysics, Escola Paulista de Medicina, has served to elevate the importance of the KLKs in serious Universidade Federal de Sao Paulo, Rua Tres de Maio 100, human disease and their diagnosis (Diamandis et al., 2000; 04044-20 Sao Paulo, Brazil Diamandis and Yousef, 2001; Yousef and Diamandis, 2001, 3 Program for Molecular Neuroscience and Departments of 2003;
    [Show full text]
  • View the Abstracts
    Journal of Leukocyte Biology Supplement 2011 ABSTRACTS 1 3 AMPK Regulation of Leukocyte Functional Polarization Macrophages as a System Jill Suttles David A. Hume University of Louisville School of Medicine, Department of The Roslin Institute, University of Edinburgh, Midlothian, Scotland, Micobiology and Immunology, Louisville, KY UK In our studies of the function of fatty acid-binding proteins (FABPs) Mononuclear phagocytes are a family of cells that participate in leukocytes we found that expression of these lipid chaperones in tissue remodelling during development, wound healing promotes inflammatory activity. Absence of FABP expression and tissue homeostasis. They are central to innate immunity, in macrophages and dendritic cells (DC) results in a polarized control subsequent acquired immune responses and contribute anti-inflammatory state and is accompanied by elevated activity to the pathology of tissue injury and inflammation. With the of AMP-activated protein kinase (AMPK) a conserved serine/ escalation of genome-scale data derived from macrophages and threonine kinase involved in the regulation of cellular energy related hematopoietic cell types, there is a growing need for an status. An investigation of the contribution of AMPK to the integrated resource that seeks to compile, organise and analyse our reduced inflammatory potential of FABP-deficient cells revealed collective knowledge of macrophage biology. We have developed AMPK as an upstream regulator of an Akt/GSK3/CREB pathway a community-driven web-based resource, www.macrophages. that promotes expression of IL-10 while inhibiting the activity of com, that aims to provide a portal onto various types of ‘omics NF-kB. In wild-type macrophages and DC, AMPK is activated by data to facilitate comparative genomic studies, promoter and a variety of anti-inflammatory stimuli and is required for IL-10 transcriptional network analyses, models of macrophage pathways induction of SOCS3 expression.
    [Show full text]
  • Activation Profiles and Regulatory Cascades of the Human Kallikrein-Related Peptidases Hyesook Yoon
    Florida State University Libraries Electronic Theses, Treatises and Dissertations The Graduate School 2008 Activation Profiles and Regulatory Cascades of the Human Kallikrein-Related Peptidases Hyesook Yoon Follow this and additional works at the FSU Digital Library. For more information, please contact [email protected] FLORIDA STATE UNIVERSITY COLLEGE OF ARTS AND SCIENCES ACTIVATION PROFILES AND REGULATORY CASCADES OF THE HUMAN KALLIKREIN-RELATED PEPTIDASES By HYESOOK YOON A Dissertation submitted to the Department of Chemistry and Biochemistry in partial fulfillment of the requirements for the degree of Doctor of Philosophy Degree Awarded: Fall Semester, 2008 The members of the Committee approve the dissertation of Hyesook Yoon defended on July 10th, 2008. ________________________ Michael Blaber Professor Directing Dissertation ________________________ Hengli Tang Outside Committee Member ________________________ Brian Miller Committee Member ________________________ Oliver Steinbock Committee Member Approved: ____________________________________________________________ Joseph B. Schlenoff, Chair, Department of Chemistry and Biochemistry The Office of Graduate Studies has verified and approved the above named committee members. ii ACKNOWLEDGMENTS I would like to dedicate this dissertation to my parents for all your support, and my sister and brother. I would also like to give great thank my advisor, Dr. Blaber for his patience, guidance. Without him, I could never make this achievement. I would like to thank to all the members in Blaber lab. They are just like family to me and I deeply appreciate their kindness, consideration and supports. I specially like to thank to Mrs. Sachiko Blaber for her endless guidance and encouragement. I would like to thank Dr Jihun Lee, Margaret Seavy, Rani and Doris Terry for helpful discussions and supports.
    [Show full text]
  • A Genomic Analysis of Rat Proteases and Protease Inhibitors
    A genomic analysis of rat proteases and protease inhibitors Xose S. Puente and Carlos López-Otín Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, 33006-Oviedo, Spain Send correspondence to: Carlos López-Otín Departamento de Bioquímica y Biología Molecular Facultad de Medicina, Universidad de Oviedo 33006 Oviedo-SPAIN Tel. 34-985-104201; Fax: 34-985-103564 E-mail: [email protected] Proteases perform fundamental roles in multiple biological processes and are associated with a growing number of pathological conditions that involve abnormal or deficient functions of these enzymes. The availability of the rat genome sequence has opened the possibility to perform a global analysis of the complete protease repertoire or degradome of this model organism. The rat degradome consists of at least 626 proteases and homologs, which are distributed into five catalytic classes: 24 aspartic, 160 cysteine, 192 metallo, 221 serine, and 29 threonine proteases. Overall, this distribution is similar to that of the mouse degradome, but significatively more complex than that corresponding to the human degradome composed of 561 proteases and homologs. This increased complexity of the rat protease complement mainly derives from the expansion of several gene families including placental cathepsins, testases, kallikreins and hematopoietic serine proteases, involved in reproductive or immunological functions. These protease families have also evolved differently in the rat and mouse genomes and may contribute to explain some functional differences between these two closely related species. Likewise, genomic analysis of rat protease inhibitors has shown some differences with the mouse protease inhibitor complement and the marked expansion of families of cysteine and serine protease inhibitors in rat and mouse with respect to human.
    [Show full text]
  • Control of the Physical and Antimicrobial Skin Barrier by an IL-31–IL-1 Signaling Network
    The Journal of Immunology Control of the Physical and Antimicrobial Skin Barrier by an IL-31–IL-1 Signaling Network Kai H. Ha¨nel,*,†,1,2 Carolina M. Pfaff,*,†,1 Christian Cornelissen,*,†,3 Philipp M. Amann,*,4 Yvonne Marquardt,* Katharina Czaja,* Arianna Kim,‡ Bernhard Luscher,€ †,5 and Jens M. Baron*,5 Atopic dermatitis, a chronic inflammatory skin disease with increasing prevalence, is closely associated with skin barrier defects. A cy- tokine related to disease severity and inhibition of keratinocyte differentiation is IL-31. To identify its molecular targets, IL-31–dependent gene expression was determined in three-dimensional organotypic skin models. IL-31–regulated genes are involved in the formation of an intact physical skin barrier. Many of these genes were poorly induced during differentiation as a consequence of IL-31 treatment, resulting in increased penetrability to allergens and irritants. Furthermore, studies employing cell-sorted skin equivalents in SCID/NOD mice demonstrated enhanced transepidermal water loss following s.c. administration of IL-31. We identified the IL-1 cytokine network as a downstream effector of IL-31 signaling. Anakinra, an IL-1R antagonist, blocked the IL-31 effects on skin differentiation. In addition to the effects on the physical barrier, IL-31 stimulated the expression of antimicrobial peptides, thereby inhibiting bacterial growth on the three-dimensional organotypic skin models. This was evident already at low doses of IL-31, insufficient to interfere with the physical barrier. Together, these findings demonstrate that IL-31 affects keratinocyte differentiation in multiple ways and that the IL-1 cytokine network is a major downstream effector of IL-31 signaling in deregulating the physical skin barrier.
    [Show full text]
  • A Suite of Activity-Based Probes to Dissect the KLK Activome in Drug-Resistant Prostate Cancer
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.15.439906; this version posted April 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. A suite of activity-based probes to dissect the KLK activome in drug-resistant prostate cancer 1 1 2,3 1 3 Scott Lovell, Leran Zhang, Thomas Kryza, Anna Neodo, Nathalie Bock, Elizabeth D. 3 1 1 1 Williams, Elisabeth Engelsberger, Congyi Xu, Alexander T. Bakker, Elena De Vita,1 Maria 3 Maneiro,1 Reiko J. Tanaka,4 Charlotte L. Bevan5 Judith A. Clements and Edward W. Tate*,1,6 1 Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London, W12 0BZ, UK 2 Mater Research Institute – The University of Queensland, Translational Research Institute, Woolloongabba, QLD, Australia 3 Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), Institute of Health & Biomedical Innovation and School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Translational Research Institute, Woolloongabba, Australia 4 Department of Bioengineering, Imperial College London, London, SW7 2AZ, UK 5 Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK 6 The Francis Crick Institute, London, NW1 1AT, UK *Correspondence should be addressed to E.W.T. ([email protected]) Abstract: Kallikrein-related peptidases (KLKs) are a family of secreted serine proteases, which form a network – the KLK activome – with an important role in proteolysis and signaling. In prostate cancer (PCa), increased KLK activity promotes tumor growth and metastasis through multiple biochemical pathways, and specific quantification and tracking of changes in the KLK activome could contribute to validation of KLKs as potential drug targets.
    [Show full text]